ASX:RAC - Long Shortz with Racura: Tackling MYC-driven cancer pathways

Racura Oncology InvestorHub

Long Shortz with Racura: Tackling MYC-driven cancer pathways

Host Tylah Tully sits down with Racura Oncology (ASX:RAC) Executive Chair Dr Pete Smith to discuss the company’s HARNESS-1 lung cancer trial. Watch the full video here.

Your question will be sent privately to Racura Oncology. The company may choose to make this question public.

Start the conversation

Ask Racura Oncology a question about this update.

Share your feedback

Discover